Jane G. Binz - Concepedia

Concepedia

Author

Jane G. Binz

Research Triangle Park Foundation

Also Known As

J G Binz, J. G. Binz, J.G. Binz, Jane Binz, Jane G Binz, Jane G. Binz

13

Publications

1.3K

Citations

9

H-Index

26

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)High Throughput Biology (United States)Institut des Maladies Métaboliques et Cardiovasculaires Institute of Laboratory Animal Science

JG

About

Jane G. Binz is an author at Research Triangle Park Foundation specializing in physiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.1K
2	Health Sciences	3	3	630
3	Biochemistry	3	3	972
4	Diabetes	2	2	252
5	Natural Sciences	1	1	426

Jane G. Binz

×

9

Publications

1.3K

Citations

9

H-Index

	Year	Citations
Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines Jon L. Collins, Adam M. Fivush, Michael A. Watson, Journal of Medicinal Chemistry Combinatorial ChemistryPharmacotherapyMolecular PharmacologyMedicinal ChemistryOxysterol	2002	426
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis Yaping Liu, Jane G. Binz, Mary Jo Numerick, Journal of Clinical Investigation Extrahepatic CholestasisGastroenterologyPathologyRat ModelsFarnesoid X Receptor	2003	378
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Kathleen K. Brown, Brad R. Henke, Steven G. Blanchard, Diabetes Insulin SignalingPeroxisome Proliferator-activated ReceptorMetabolic SyndromeDiabetic PhenotypeHealth Sciences	1999	168
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction James M. Lenhard, Mary E. Lancaster, Mark Paulik, Diabetologia Metabolic SyndromeDiabetes ManagementMedicinePhysiologyDiabetes	1999	84
GI262570, a Peroxisome Proliferator-Activated Receptor γ Agonist, Changes Electrolytes and Water Reabsorption from the Distal Nephron in Rats Lihong Chen, Baichun Yang, Judi A. McNulty, Journal of Pharmacology and Experimental Therapeutics	2005	75
The Effect of PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>α</mml:mi></mml:math>, PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>δ</mml:mi></mml:math>, PPAR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math>, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice W. Wallace Harrington, Christy S. Britt, Joan G. Wilson, PPAR Research	2007	69
Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats James G. Conway, Heather M. Pink, Mandy L. Bergquist, Journal of Pharmacology and Experimental Therapeutics	2008	54
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis Yaping Liu, Jane G. Binz, Mary Jo Numerick, Journal of Clinical Investigation	2003	36
Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice Kamal Albarazanji, Judi A. McNulty, Jane G. Binz, Journal of Pharmacology and Experimental Therapeutics	2015	19

Page 1